Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment. ObjectiveGeneralized...
Gespeichert in:
Veröffentlicht in: | The American journal of psychiatry 2013-07, Vol.170 (7), p.782-789 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 789 |
---|---|
container_issue | 7 |
container_start_page | 782 |
container_title | The American journal of psychiatry |
container_volume | 170 |
creator | Wetherell, Julie Loebach Petkus, Andrew J. White, Kamila S. Nguyen, Hoang Kornblith, Sander Andreescu, Carmen Zisook, Sidney Lenze, Eric J. |
description | Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment.
ObjectiveGeneralized anxiety disorder is common among older adults and leads to diminished health and cognitive functioning. Although antidepressant medications are efficacious, many elderly individuals require augmentation treatment. Furthermore, little is known about maintenance strategies for older people. The authors examined whether sequenced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and prevents relapse in older adults with generalized anxiety disorder.MethodParticipants were individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited from outpatient clinics at three sites. Participants received 12 weeks of open-label escitalopram and were then randomly assigned to one of four conditions: 16 weeks of escitalopram (10–20 mg/day) plus modular CBT, followed by 28 weeks of maintenance escitalopram; escitalopram alone, followed by maintenance escitalopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placebo.ResultsEscitalopram augmented with CBT increased response rates on the Penn State Worry Questionnaire but not on the Hamilton Anxiety Rating Scale compared with escitalopram alone. Both escitalopram and CBT prevented relapse compared with placebo.ConclusionsThis study demonstrates effective strategies for treatment of generalized anxiety disorder in older adults. The sequence of antidepressant medication augmented with CBT leads to worry reduction in the short-term. Continued medication prevents relapse, but for many individuals, CBT would allow sustained remission without requiring long-term pharmacotherapy. |
doi_str_mv | 10.1176/appi.ajp.2013.12081104 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4090227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3090293011</sourcerecordid><originalsourceid>FETCH-LOGICAL-a549t-61bea600c14cffb645b7cb6ab72352dfb6d026771f2a400bc7447d3f4f55ecac3</originalsourceid><addsrcrecordid>eNqFkk2P0zAQhi0EYsvCX1hZQkhcUvwZJxekUGBBWrSXRXCzHMdpXaV2sJ2K8utxaHcXOMDJX8-8M-N5AbjAaImxKF-pcbRLtR2XBGG6xARVGCP2ACwwp7wQhFQPwQIhRIqa069n4EmM23xEVJDH4IzQssoRYgH2jUu2M2MwMSqX4CfTWa2S9Q4203pnXDId_GLTBq782tlk96Z4YzZqb31QA7zZmKDGA-x9gJfG5cNgf-SIxn23Jh3gWxt96EyA1sHrYd403TSk-BQ86tUQzbPTeg4-v393s_pQXF1fflw1V4XirE5FiVujSoQ0Zrrv25LxVui2VK0glJMu33SIlELgniiGUKsFY6KjPes5N1ppeg5eH3XHqd2ZTud-colyDHanwkF6ZeWfL85u5NrvJUM1IkRkgZcngeC_TSYmubNRm2FQzvgpSsw5oaKsCP8_Smta5cGgOqPP_0K3fgou_4TEjNYcC4JmwfJI6eBjDKa_qxsjObtAzi6Q2QVydoG8dUEOvPi967uw27Fn4MUJUFGroQ_KaRvvOcHqmolZiB65X4nua_x3-p9rxc9i</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1439517205</pqid></control><display><type>article</type><title>Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults</title><source>MEDLINE</source><source>American Psychiatric Publishing Journals (1997-Present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Wetherell, Julie Loebach ; Petkus, Andrew J. ; White, Kamila S. ; Nguyen, Hoang ; Kornblith, Sander ; Andreescu, Carmen ; Zisook, Sidney ; Lenze, Eric J.</creator><creatorcontrib>Wetherell, Julie Loebach ; Petkus, Andrew J. ; White, Kamila S. ; Nguyen, Hoang ; Kornblith, Sander ; Andreescu, Carmen ; Zisook, Sidney ; Lenze, Eric J.</creatorcontrib><description>Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment.
ObjectiveGeneralized anxiety disorder is common among older adults and leads to diminished health and cognitive functioning. Although antidepressant medications are efficacious, many elderly individuals require augmentation treatment. Furthermore, little is known about maintenance strategies for older people. The authors examined whether sequenced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and prevents relapse in older adults with generalized anxiety disorder.MethodParticipants were individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited from outpatient clinics at three sites. Participants received 12 weeks of open-label escitalopram and were then randomly assigned to one of four conditions: 16 weeks of escitalopram (10–20 mg/day) plus modular CBT, followed by 28 weeks of maintenance escitalopram; escitalopram alone, followed by maintenance escitalopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placebo.ResultsEscitalopram augmented with CBT increased response rates on the Penn State Worry Questionnaire but not on the Hamilton Anxiety Rating Scale compared with escitalopram alone. Both escitalopram and CBT prevented relapse compared with placebo.ConclusionsThis study demonstrates effective strategies for treatment of generalized anxiety disorder in older adults. The sequence of antidepressant medication augmented with CBT leads to worry reduction in the short-term. Continued medication prevents relapse, but for many individuals, CBT would allow sustained remission without requiring long-term pharmacotherapy.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/appi.ajp.2013.12081104</identifier><identifier>PMID: 23680817</identifier><identifier>CODEN: AJPSAO</identifier><language>eng</language><publisher>Arlington, VA: American Psychiatric Association</publisher><subject>Adult and adolescent clinical studies ; Aged ; Antidepressants ; Antidepressive Agents, Second-Generation - therapeutic use ; Anxiety ; Anxiety Disorders - drug therapy ; Anxiety Disorders - therapy ; Anxiety disorders. Neuroses ; Behavior therapy. Cognitive therapy ; Biological and medical sciences ; Citalopram - therapeutic use ; Clinical outcomes ; Cognitive therapy ; Cognitive Therapy - methods ; Combined Modality Therapy ; Drug therapy ; Female ; Humans ; Male ; Medical sciences ; Miscellaneous ; Neuropharmacology ; Older people ; Pharmacology. Drug treatments ; Psychiatric Status Rating Scales ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Surveys and Questionnaires ; Treatments</subject><ispartof>The American journal of psychiatry, 2013-07, Vol.170 (7), p.782-789</ispartof><rights>Copyright © 2013 by the American Psychiatric Association 2013</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 by the American Psychiatric Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a549t-61bea600c14cffb645b7cb6ab72352dfb6d026771f2a400bc7447d3f4f55ecac3</citedby><cites>FETCH-LOGICAL-a549t-61bea600c14cffb645b7cb6ab72352dfb6d026771f2a400bc7447d3f4f55ecac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/appi.ajp.2013.12081104$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/appi.ajp.2013.12081104$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>230,314,776,780,881,2841,21606,21607,21608,27903,27904,77540,77545</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27499474$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23680817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wetherell, Julie Loebach</creatorcontrib><creatorcontrib>Petkus, Andrew J.</creatorcontrib><creatorcontrib>White, Kamila S.</creatorcontrib><creatorcontrib>Nguyen, Hoang</creatorcontrib><creatorcontrib>Kornblith, Sander</creatorcontrib><creatorcontrib>Andreescu, Carmen</creatorcontrib><creatorcontrib>Zisook, Sidney</creatorcontrib><creatorcontrib>Lenze, Eric J.</creatorcontrib><title>Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment.
ObjectiveGeneralized anxiety disorder is common among older adults and leads to diminished health and cognitive functioning. Although antidepressant medications are efficacious, many elderly individuals require augmentation treatment. Furthermore, little is known about maintenance strategies for older people. The authors examined whether sequenced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and prevents relapse in older adults with generalized anxiety disorder.MethodParticipants were individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited from outpatient clinics at three sites. Participants received 12 weeks of open-label escitalopram and were then randomly assigned to one of four conditions: 16 weeks of escitalopram (10–20 mg/day) plus modular CBT, followed by 28 weeks of maintenance escitalopram; escitalopram alone, followed by maintenance escitalopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placebo.ResultsEscitalopram augmented with CBT increased response rates on the Penn State Worry Questionnaire but not on the Hamilton Anxiety Rating Scale compared with escitalopram alone. Both escitalopram and CBT prevented relapse compared with placebo.ConclusionsThis study demonstrates effective strategies for treatment of generalized anxiety disorder in older adults. The sequence of antidepressant medication augmented with CBT leads to worry reduction in the short-term. Continued medication prevents relapse, but for many individuals, CBT would allow sustained remission without requiring long-term pharmacotherapy.</description><subject>Adult and adolescent clinical studies</subject><subject>Aged</subject><subject>Antidepressants</subject><subject>Antidepressive Agents, Second-Generation - therapeutic use</subject><subject>Anxiety</subject><subject>Anxiety Disorders - drug therapy</subject><subject>Anxiety Disorders - therapy</subject><subject>Anxiety disorders. Neuroses</subject><subject>Behavior therapy. Cognitive therapy</subject><subject>Biological and medical sciences</subject><subject>Citalopram - therapeutic use</subject><subject>Clinical outcomes</subject><subject>Cognitive therapy</subject><subject>Cognitive Therapy - methods</subject><subject>Combined Modality Therapy</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Neuropharmacology</subject><subject>Older people</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Surveys and Questionnaires</subject><subject>Treatments</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk2P0zAQhi0EYsvCX1hZQkhcUvwZJxekUGBBWrSXRXCzHMdpXaV2sJ2K8utxaHcXOMDJX8-8M-N5AbjAaImxKF-pcbRLtR2XBGG6xARVGCP2ACwwp7wQhFQPwQIhRIqa069n4EmM23xEVJDH4IzQssoRYgH2jUu2M2MwMSqX4CfTWa2S9Q4203pnXDId_GLTBq782tlk96Z4YzZqb31QA7zZmKDGA-x9gJfG5cNgf-SIxn23Jh3gWxt96EyA1sHrYd403TSk-BQ86tUQzbPTeg4-v393s_pQXF1fflw1V4XirE5FiVujSoQ0Zrrv25LxVui2VK0glJMu33SIlELgniiGUKsFY6KjPes5N1ppeg5eH3XHqd2ZTud-colyDHanwkF6ZeWfL85u5NrvJUM1IkRkgZcngeC_TSYmubNRm2FQzvgpSsw5oaKsCP8_Smta5cGgOqPP_0K3fgou_4TEjNYcC4JmwfJI6eBjDKa_qxsjObtAzi6Q2QVydoG8dUEOvPi967uw27Fn4MUJUFGroQ_KaRvvOcHqmolZiB65X4nua_x3-p9rxc9i</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Wetherell, Julie Loebach</creator><creator>Petkus, Andrew J.</creator><creator>White, Kamila S.</creator><creator>Nguyen, Hoang</creator><creator>Kornblith, Sander</creator><creator>Andreescu, Carmen</creator><creator>Zisook, Sidney</creator><creator>Lenze, Eric J.</creator><general>American Psychiatric Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>5PM</scope></search><sort><creationdate>20130701</creationdate><title>Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults</title><author>Wetherell, Julie Loebach ; Petkus, Andrew J. ; White, Kamila S. ; Nguyen, Hoang ; Kornblith, Sander ; Andreescu, Carmen ; Zisook, Sidney ; Lenze, Eric J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a549t-61bea600c14cffb645b7cb6ab72352dfb6d026771f2a400bc7447d3f4f55ecac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Aged</topic><topic>Antidepressants</topic><topic>Antidepressive Agents, Second-Generation - therapeutic use</topic><topic>Anxiety</topic><topic>Anxiety Disorders - drug therapy</topic><topic>Anxiety Disorders - therapy</topic><topic>Anxiety disorders. Neuroses</topic><topic>Behavior therapy. Cognitive therapy</topic><topic>Biological and medical sciences</topic><topic>Citalopram - therapeutic use</topic><topic>Clinical outcomes</topic><topic>Cognitive therapy</topic><topic>Cognitive Therapy - methods</topic><topic>Combined Modality Therapy</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Neuropharmacology</topic><topic>Older people</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Surveys and Questionnaires</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wetherell, Julie Loebach</creatorcontrib><creatorcontrib>Petkus, Andrew J.</creatorcontrib><creatorcontrib>White, Kamila S.</creatorcontrib><creatorcontrib>Nguyen, Hoang</creatorcontrib><creatorcontrib>Kornblith, Sander</creatorcontrib><creatorcontrib>Andreescu, Carmen</creatorcontrib><creatorcontrib>Zisook, Sidney</creatorcontrib><creatorcontrib>Lenze, Eric J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wetherell, Julie Loebach</au><au>Petkus, Andrew J.</au><au>White, Kamila S.</au><au>Nguyen, Hoang</au><au>Kornblith, Sander</au><au>Andreescu, Carmen</au><au>Zisook, Sidney</au><au>Lenze, Eric J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>170</volume><issue>7</issue><spage>782</spage><epage>789</epage><pages>782-789</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><coden>AJPSAO</coden><abstract>Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment.
ObjectiveGeneralized anxiety disorder is common among older adults and leads to diminished health and cognitive functioning. Although antidepressant medications are efficacious, many elderly individuals require augmentation treatment. Furthermore, little is known about maintenance strategies for older people. The authors examined whether sequenced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and prevents relapse in older adults with generalized anxiety disorder.MethodParticipants were individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited from outpatient clinics at three sites. Participants received 12 weeks of open-label escitalopram and were then randomly assigned to one of four conditions: 16 weeks of escitalopram (10–20 mg/day) plus modular CBT, followed by 28 weeks of maintenance escitalopram; escitalopram alone, followed by maintenance escitalopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placebo.ResultsEscitalopram augmented with CBT increased response rates on the Penn State Worry Questionnaire but not on the Hamilton Anxiety Rating Scale compared with escitalopram alone. Both escitalopram and CBT prevented relapse compared with placebo.ConclusionsThis study demonstrates effective strategies for treatment of generalized anxiety disorder in older adults. The sequence of antidepressant medication augmented with CBT leads to worry reduction in the short-term. Continued medication prevents relapse, but for many individuals, CBT would allow sustained remission without requiring long-term pharmacotherapy.</abstract><cop>Arlington, VA</cop><pub>American Psychiatric Association</pub><pmid>23680817</pmid><doi>10.1176/appi.ajp.2013.12081104</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-953X |
ispartof | The American journal of psychiatry, 2013-07, Vol.170 (7), p.782-789 |
issn | 0002-953X 1535-7228 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4090227 |
source | MEDLINE; American Psychiatric Publishing Journals (1997-Present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Adult and adolescent clinical studies Aged Antidepressants Antidepressive Agents, Second-Generation - therapeutic use Anxiety Anxiety Disorders - drug therapy Anxiety Disorders - therapy Anxiety disorders. Neuroses Behavior therapy. Cognitive therapy Biological and medical sciences Citalopram - therapeutic use Clinical outcomes Cognitive therapy Cognitive Therapy - methods Combined Modality Therapy Drug therapy Female Humans Male Medical sciences Miscellaneous Neuropharmacology Older people Pharmacology. Drug treatments Psychiatric Status Rating Scales Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Surveys and Questionnaires Treatments |
title | Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T01%3A34%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antidepressant%20Medication%20Augmented%20With%20Cognitive-Behavioral%20Therapy%20for%20Generalized%20Anxiety%20Disorder%20in%20Older%20Adults&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=Wetherell,%20Julie%20Loebach&rft.date=2013-07-01&rft.volume=170&rft.issue=7&rft.spage=782&rft.epage=789&rft.pages=782-789&rft.issn=0002-953X&rft.eissn=1535-7228&rft.coden=AJPSAO&rft_id=info:doi/10.1176/appi.ajp.2013.12081104&rft_dat=%3Cproquest_pubme%3E3090293011%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1439517205&rft_id=info:pmid/23680817&rfr_iscdi=true |